$GILD declining to flat sales. No growth in near term from pipeline. Lots of cash. Sector a lot cheaper. What were they waiting for again?
The only thing more tired than the biotech bubble discussion is the Greek discussion and it looks like tomorrow/tonight we have both.
FYI, $GILD has enough cash flow to do a buyback and M&A. The idea that they are mutually exclusive is a false dichotomy.